US FDA approves Verrica's skin disease treatment
July 21 (Reuters) - The U.S. Food and Drug Administration has approved Verrica Pharmaceuticals Inc's VRCA.O treatment of a viral skin disease in adults and children aged 2 years and above, the company said on Friday. (Reporting by Khushi Mandowara and Sriparna Roy in Bengaluru; Editing by Shailesh Kuber) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data